Tag Archive for: Molecular Diagnostics

IVD in Egypt: $440 Million Market Lead by Immunodiagnostic and Molecular Diagnostic Growth

In Egypt, like many other countries, the elderly population is growing rapidly, increasing at a rate of 5.1% annually, which is more than double the growth rate of the total population. This demographic shift, coupled with a large rural population requiring satellite care and mobile services, poses significant challenges for the healthcare system, according to […]

2023 Healthcare Trend: Growth in $21 Billion Molecular Diagnostics Market

Future molecular IVD sales buoyed by COVID-19, infectious diseases, and sexually transmitted infections There is a market in excess of $21 billion for molecular testing technologies, reveals medical market research publisher Kalorama Information in The World Market for Molecular Diagnostics Tests, 11th Edition, a recent report added to the firm’s Knowledge Center subscription.  The majority […]

COVID-19 Testing Increases Value of Global Molecular Diagnostics Market

As the COVID-19 crisis surfaced in the United States, molecular diagnostic manufacturers went to work with new RT-PCR testing kits. The worldwide demand for COVID tests has materialized rapidly from zero and already on course become a 1.3 billion-dollar market in the first half of 2020.  There have been hundreds of tests on the market […]

In Breaking Transmission Chain of COVID-19 and Other Diseases, Point-of-Care is Best Hope

Demand for testing has gone from a healthcare industry topic to a national crusade in weeks with the onset of COVID-19. High-throughput tests have been approved by the U.S. Food and Drug Administration (FDA) for use in the U.S. for the detection of SARS-CoV-2, the virus behind the disease. But for true intervention in doctors […]

Molecular Diagnostics for Cancer Grows, Fueled by NGS-based Testing

Cancer diagnostics is a highly dynamic field that consists of various types of platforms. Molecular diagnostics platforms are increasingly becoming popular as they enable accurate diagnosis as well as prognosis evaluation, which are important for treatment decisions. In 2019, the market for molecular cancer diagnostics, including histology and assays, reached $1,600 million, increasing 11.5% over […]